Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease
Yash Pal Singh, Gullanki Naga Venkata Charan Tej, Amruta Pandey, et al.
European Journal of Medicinal Chemistry (2020) Vol. 198, pp. 112257-112257
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Zhipei Sang, Keren Wang, Jianghong Dong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114464-114464
Closed Access | Times Cited: 80
A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease
Yash Pal Singh, Himanshu Rai, Gourav Singh, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113278-113278
Closed Access | Times Cited: 76
Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer’s Disease
Himanshu Rai, Sarika Gupta, Saroj Kumar, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 8550-8595
Closed Access | Times Cited: 47
Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease
Kancharla Bhanukiran, Gajendra T.A., Sairam Krishnamurthy, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115145-115145
Closed Access | Times Cited: 22
Research progress of natural products and their derivatives against Alzheimer’s disease
Jinying Liu, Hongyan Guo, Zhe‐Shan Quan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 21
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents
Elisabetta Barresi, Emma Baglini, Valeria Poggetti, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2127-2127
Open Access | Times Cited: 11
Vasicinone, a pyrroloquinazoline alkaloid from Adhatoda vasica Nees enhances memory and cognition by inhibiting cholinesterases in Alzheimer's disease
Kancharla Bhanukiran, Ravi Singh, T A Gajendra, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100439-100439
Open Access | Times Cited: 19
Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease
Nilesh Gajanan Bajad, Ravi Bhushan Singh, Gajendra T.A., et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107082-107082
Closed Access | Times Cited: 5
Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer’s Disease
Gourav Singh, Gauri Shankar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1388-1414
Closed Access | Times Cited: 5
Discovery of pyrazoline analogs as multi-targeting cholinesterase, β-secretase and Aβ aggregation inhibitors through lead optimization strategy
Nilesh Gajanan Bajad, Jatin Jangra, T A Gajendra, et al.
International Journal of Biological Macromolecules (2025), pp. 140436-140436
Closed Access
Multicomponent Synthesis of S-Benzyl Dithiocarbamates from para-Quinone Methides and Their Biological Evaluation for the Treatment of Alzheimer’s Disease
Rapelly Venkatesh, Gauri Shankar, Aswathi C. Narayanan, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 10, pp. 6730-6741
Closed Access | Times Cited: 26
Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design
Manish Tripathi, Bhagwati Bhardwaj, Digambar Kumar Waiker, et al.
Journal of Molecular Structure (2023) Vol. 1286, pp. 135517-135517
Closed Access | Times Cited: 14
Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer’s Disease
Digambar Kumar Waiker, Akash Verma, Poorvi Saraf, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 9394-9414
Open Access | Times Cited: 13
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review
Yash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1624-1651
Closed Access | Times Cited: 13
Drug repurposing for Alzheimer’s disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors
Navneet Kumar, Anuj Gahlawat, Rajaram Naresh Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 7, pp. 2878-2892
Closed Access | Times Cited: 35
Promising heterocycle-based scaffolds in recent (2019–2021) anti-Alzheimer's drug design and discovery
Atukuri Dorababu
European Journal of Pharmacology (2022) Vol. 920, pp. 174847-174847
Closed Access | Times Cited: 21
A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease
Gourav Singh, Sunil Kumar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2756-2778
Closed Access | Times Cited: 3
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 3
Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer’s disease
Yash Pal Singh, Gauri Shankar, Shagufta Jahan, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116385-116385
Closed Access | Times Cited: 24
Exploration of Neuroprotective Properties of a Naturally Inspired Multifunctional Molecule (F24) against Oxidative Stress and Amyloid β Induced Neurotoxicity in Alzheimer’s Disease Models
Yash Pal Singh, Navneet Kumar, Khushbu Priya, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 27-42
Closed Access | Times Cited: 21
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Honghua Zhang, Yan Peng, Linsheng Zhuo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114695-114695
Closed Access | Times Cited: 15
Equilibria of complexes in the aqueous cobalt(II)–N-(2-hydroxybenzyl)phenylalanine system and their biological activity compared to analogous Schiff base structures
Magdalena Woźniczka, Mirosława Świątek, Manas Sutradhar, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1312-1323
Open Access | Times Cited: 8
Advances in multi-target fluorescent probes for imaging and analyzing biomarkers in Alzheimer’s disease
Chaofeng Zhu, Jiahao Han, Fanghui Liang, et al.
Coordination Chemistry Reviews (2024) Vol. 517, pp. 216002-216002
Open Access | Times Cited: 2
Screening and identification of acetylcholinesterase inhibitors from Terminalia chebula fruits by immobilized enzyme on cellulose filter paper coupled with ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry and molecular docking
Yan-Jun Li, Fu-Qin He, Huan-Huan Zhao, et al.
Journal of Chromatography A (2021) Vol. 1663, pp. 462784-462784
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top